Volume 3, Issue 8 p. 1493-1513
PRN OPINION PAPER

Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy

Scott A. Coon Pharm.D.

Corresponding Author

Scott A. Coon Pharm.D.

Department of Pharmacotherapeutics & Clinical Research, University of South Florida, Taneja College of Pharmacy, Morsani College of Medicine, Tampa, Florida, USA

Correspondence

Scott A. Coon, Department of Pharmacotherapeutics and Clinical Research, Taneja College of Pharmacy, University of South Florida, 12901 Bruce B. Downs Blvd., MDC 30, Tampa, FL 33612.

Email: [email protected]

Search for more papers by this author
Lucas G. Hill Pharm.D.

Lucas G. Hill Pharm.D.

Division of Pharmacy Practice, The University of Texas at Austin College of Pharmacy, Austin, Texas, USA

Search for more papers by this author
Robert W. Hutchison Pharm.D.

Robert W. Hutchison Pharm.D.

Department of Pharmacy Practice, Texas A&M Irma Lerma Rangel College of Pharmacy, Round Rock, Texas, USA

Search for more papers by this author
Lindsay M. Arnold Pharm.D.

Lindsay M. Arnold Pharm.D.

Department of Pharmacy Services, St. Elizabeth's Medical Center, Brighton, Massachusetts, USA

Search for more papers by this author
Jennie B. Jarrett Pharm.D., MMedEd, FCCP

Jennie B. Jarrett Pharm.D., MMedEd, FCCP

Department of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois, USA

Search for more papers by this author
Anne R. Ottney Pharm.D.

Anne R. Ottney Pharm.D.

Department of Pharmacy Practice, Ferris State University, College of Pharmacy, Big Rapids, Michigan, USA

Search for more papers by this author
Alvin B. Oung Pharm.D.

Alvin B. Oung Pharm.D.

Department of Pharmacy Practice, University of Wyoming School of Pharmacy, Laramie, Wyoming, USA

Search for more papers by this author
Nathan A. Painter Pharm.D.

Nathan A. Painter Pharm.D.

Division of Clinical Pharmacy, University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, California, USA

Search for more papers by this author
Michael A. Smith Pharm.D.

Michael A. Smith Pharm.D.

Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA

Search for more papers by this author
Paul M. Stranges Pharm.D.

Paul M. Stranges Pharm.D.

Department of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois, USA

Search for more papers by this author
Tran H. Tran Pharm.D.

Tran H. Tran Pharm.D.

Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois, USA

Search for more papers by this author
Amanda R. McFee Winans Pharm.D.

Amanda R. McFee Winans Pharm.D.

Section of Clinical Pharmacy, Department of Pharmaceutical Care Services, Bassett Medical Center, Cooperstown, New York, USA

Search for more papers by this author
Jeffrey P. Bratberg Pharm.D.

Jeffrey P. Bratberg Pharm.D.

Department of Pharmacy Practice, University of Rhode Island College of Pharmacy, Kingston, Rhode Island, USA

Search for more papers by this author
First published: 29 September 2020
Citations: 22

This paper represents the opinion of the Adult Medicine and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy. It does not necessarily represent an official ACCP commentary, guideline, or statement of policy or position.

Abstract

The opioid crisis represents one of the largest failures of our current health care system as it continues to claim lives at an unprecedented rate and has caused a devastating range of preventable morbidity. Although the availability of highly potent synthetic opioids has amplified the urgency of the crisis for patients and communities, this problem has evolved over several decades. Pharmacists are in a position to offer many potential solutions due to their widespread accessibility, extensive drug knowledge, and integration into various health care settings. This opinion paper challenges the status quo by calling on all pharmacists to embrace evidence-based opioid stewardship and harm reduction practices, contribute to the medical management of opioid use disorder, and address the misconceptions and prejudices that serve as barriers to effective, compassionate patient care. Regardless of practice setting or available resources, pharmacists can take deliberate and impactful steps to address the opioid crisis. Some pharmacists may be positioned to implement innovative and far-reaching pharmacist-led clinical services, while others may simply begin with careful consideration of the language they use when speaking to and about patients with substance use disorders. To optimize patient outcomes, the ineffective laws, regulations, and policies that negatively impact pain and addiction care must be addressed so that evidence-based solutions can be widely disseminated. Pharmacists must aggressively advocate for the removal of barriers preventing high-level clinical practice or policies that perpetuate patient harm and abandonment. Finally, there must be support for continued research on pain and opioid use disorder treatments and services, as well as the impacts of harm reduction practices and pharmacist-led clinical services, so that resources can be allocated effectively.

CONFLICT OF INTEREST

The authors declare no conflicts of interest.